Johnson & Johnson Клинические исследования

Клинические исследования компании Johnson & Johnson: фазы, заболевания и опубликованные результаты.

• A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
  Фаза 3 · Crohn Disease · Идёт, набор закрыт · 21.02.2025
• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Di
  Фаза 2/3 · Crohn's Disease · Идёт, набор закрыт · 7.05.2025
• A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non
  Фаза 2 · Urinary Bladder Neoplasms · Идёт, набор закрыт · 29.07.2026
• Premedication to Reduce Amivantamab Associated Infusion Related Reactions
  Фаза 2 · Carcinoma, Non-Small-Cell Lung · Идёт, набор закрыт · 20.10.2025
• A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With
  Фаза 3 · Advanced or Metastatic Non-small Cell Lung Cancer · Идёт, набор закрыт · 2.02.2026
• A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Pre
  Фаза 3 · Castration-Resistant Prostatic Cancer · Идёт, набор закрыт · 4.10.2023
• A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
  Фаза 3 · Crohn Disease · Завершено · 30.07.2026
• A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-B
  Фаза 3 · Carcinoma, Non-Small-Cell Lung · Идёт, набор закрыт · 16.04.2025
• A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CR
  Фаза 4 · Prostatic Neoplasms · Завершено · 28.03.2025
• A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
  Фаза 2/3 · Ulcerative Colitis · Идёт, набор закрыт · 18.11.2024
• A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
  Фаза 3 · Myasthenia Gravis · Набор · 23.07.2025
• A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis
  Фаза 2 · Arthritis, Psoriatic · Завершено · 23.07.2026
• A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Vi
  Фаза 2 · Hepatitis D, Chronic · Завершено · 6.11.2024
• A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
  Фаза 3 · Plaque Psoriasis · Идёт, набор закрыт · 25.06.2026
• Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-T
  Фаза 3 · Arthritis, Psoriatic · Идёт, набор закрыт · 8.12.2025

Исследования по компаниям

PfizerMerck (MSD)RocheNovartisAstraZenecaJohnson & JohnsonBristol Myers SquibbSanofiGSKEli LillyAbbVieAmgenBayerBoehringer IngelheimNovo NordiskTakedaGilead SciencesModernaBioNTechRegeneronVertexBiogenDaiichi SankyoAstellas PharmaEisaiOtsukaServierIncyteCelltrionSamsung BioepisHanmi PharmaceuticalYuhan

Все исследования